A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

ArQule

ClinicalTrials.gov Identifier:

NCT00558207

First received: November 12, 2007

Last updated: February 21, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2008
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	February 21, 2013